[fcb5af]: / literature / by_gene_clean / TNFRSF14.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 34265801 10.1097/PAS.0000000000001780 2022 Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. TNFRSF14
2 34382383 10.3324/haematol.2020.263251 2022 Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma. TNFRSF14
3 35038193 10.1111/his.14617 2022 Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort. TNFRSF14
4 35106936 10.1002/cam4.4550 2022 SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups. TNFRSF14
5 35609565 10.1182/bloodadvances.2022007322 2022 A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile. TNFRSF14
6 35734168 10.3389/fimmu.2022.922471 2022 m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment. TNFRSF14
7 35834399 10.1097/PAS.0000000000001932 2022 Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features. TNFRSF14
8 32855278 10.3324/haematol.2020.254854 2021 Genetic evolution of <i>in situ</i> follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype. TNFRSF14
9 33311649 10.1038/s41379-020-00720-7 2021 Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice. TNFRSF14
10 33395752 10.1016/j.tranon.2020.100977 2021 Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation. TNFRSF14
11 33560380 10.1182/bloodadvances.2020002469 2021 Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features. TNFRSF14
12 33562694 10.3390/cancers13040641 2021 Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention. TNFRSF14
13 33945543 10.1371/journal.pone.0248886 2021 Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes. TNFRSF14
14 33959502 10.3389/fonc.2021.638897 2021 c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study. TNFRSF14
15 33964277 10.1016/j.humpath.2021.04.014 2021 Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma. TNFRSF14
16 34021249 10.1038/s41375-021-01289-z 2021 Thyroid MALT lymphoma: self-harm to gain potential T-cell help. TNFRSF14
17 34069564 10.3390/ijms22105352 2021 The Tumor Microenvironment in Follicular Lymphoma: Its Pro-Malignancy Role with Therapeutic Potential. TNFRSF14
18 34374220 10.1002/cjp2.223 2021 c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma. TNFRSF14
19 34478526 10.1182/bloodadvances.2021005215 2021 Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype. TNFRSF14
20 34558064 10.1111/bjh.17824 2021 Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases. TNFRSF14
21 34671837 10.1007/s00292-021-01011-x 2021 [Genetic evolution of in situ follicular neoplasia to t(14;18)-positive aggressive B-cell lymphoma]. TNFRSF14
22 35008340 10.3390/cancers14010176 2021 Recent Advances in the Genetic of MALT Lymphomas. TNFRSF14
23 32012328 10.1002/hon.2718 2020 High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. TNFRSF14
24 32239385 10.1007/s11523-020-00710-4 2020 Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. TNFRSF14
25 32304999 10.1016/j.ebiom.2020.102731 2020 Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab. TNFRSF14
26 33045225 10.1016/j.humpath.2020.09.014 2020 The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. TNFRSF14
27 33188997 10.1016/j.ctarc.2020.100235 2020 Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study. TNFRSF14
28 33211828 10.1182/bloodadvances.2020002944 2020 Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. TNFRSF14
29 31368914 10.1097/PAS.0000000000001338 2019 Indolent In Situ B-Cell Neoplasms With MYC Rearrangements Show Somatic Mutations in MYC and TNFRSF14 by Next-generation Sequencing. TNFRSF14
30 29738359 10.1097/PAS.0000000000001071 2018 Genomic Profile and Pathologic Features of Diffuse Large B-Cell Lymphoma Subtype of Methotrexate-associated Lymphoproliferative Disorder in Rheumatoid Arthritis Patients. TNFRSF14
31 29858685 10.1007/s00428-018-2384-3 2018 Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein. TNFRSF14
32 30126979 10.1182/blood-2018-03-837252 2018 Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles. TNFRSF14
33 27297871 10.1111/his.13015 2017 Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications. TNFRSF14
34 28533310 10.1182/blood-2017-03-776278 2017 Mutations of <i>MAP2K1</i> are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. TNFRSF14
35 27098631 NA 2016 Extranodal B Cell Lymphoma with Prominent Spindle Cell Features Arising in Uterus and in Maxillary Sinus: Report of Two Cases and Literature Review. TNFRSF14
36 27257180 10.1182/blood-2016-03-703819 2016 Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene. TNFRSF14
37 27325104 10.1182/blood-2015-12-682591 2016 Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations. TNFRSF14
38 27750045 10.1016/j.ajpath.2016.07.027 2016 B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains. TNFRSF14
39 26366710 10.1038/nm.3943 2015 The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. TNFRSF14
40 24162788 10.3324/haematol.2013.094474 2014 Early lesions of follicular lymphoma: a genetic perspective. TNFRSF14
41 24435047 10.1182/blood-2013-05-500264 2014 Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. TNFRSF14
42 24942943 10.3960/jslrt.54.23 2014 Molecular pathogenesis of follicular lymphoma. TNFRSF14
43 23297126 10.1182/blood-2012-09-457283 2013 Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. TNFRSF14
44 23445872 10.3324/haematol.2012.073916 2013 Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas. TNFRSF14
45 24052547 10.1182/blood-2013-04-496893 2013 EZH2 mutations are frequent and represent an early event in follicular lymphoma. TNFRSF14
46 22343534 10.1073/pnas.1121343109 2012 Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. TNFRSF14
47 23023713 10.1172/JCI63186 2012 Pathogenesis of follicular lymphoma. TNFRSF14
48 19573080 10.1111/j.1365-2141.2009.07790.x 2009 Common genetic variants in candidate genes and risk of familial lymphoid malignancies. TNFRSF14
49 19773279 10.1136/oem.2008.044024 2009 Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. TNFRSF14